Assessment of structurally diverse philanthotoxin analogues for inhibitory activity on ionotropic glutamate receptor subtypes: discovery of nanomolar, nonselective, and use-dependent antagonists.
暂无分享,去创建一个
M. Witt | J. Jaroszewski | A. Kristensen | K. Strømgaard | C. Olsen | H. Franzyk | H. Ziegler | A. Bella | Sidsel Frølund
[1] K. McKeage. Memantine , 2009, CNS drugs.
[2] A. Kristensen,et al. Synthesis and biological activity of argiotoxin 636 and analogues: selective antagonists for ionotropic glutamate receptors. , 2009, Angewandte Chemie.
[3] C. Parsons,et al. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-d-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors , 2009, Neuropharmacology.
[4] R. Marum. Update on the use of memantine in Alzheimer's disease. , 2009 .
[5] D. Muñoz-Torrero. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease. , 2008, Current medicinal chemistry.
[6] Chris G. Parsons,et al. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse , 2007, Neuropharmacology.
[7] S. Dravid,et al. Subunit‐specific mechanisms and proton sensitivity of NMDA receptor channel block , 2007, The Journal of physiology.
[8] M. Witt,et al. Solid-phase synthesis of neuroactive spider–wasp hybrid toxin analogues using a backbone amide linker , 2007 .
[9] L. Piazzi,et al. Protolytic properties of polyamine wasp toxin analogues studied by 13C NMR spectroscopy , 2006, Magnetic resonance in chemistry : MRC.
[10] T. Arendt,et al. The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease , 2006, Journal of Neural Transmission.
[11] Henrik Zetterberg,et al. Plasma Aβ in Alzheimer's disease—up or down? , 2006, The Lancet Neurology.
[12] M. Mayer. Glutamate receptors at atomic resolution , 2006, Nature.
[13] M. Witt,et al. Tuning Wasp Toxin Structure for Nicotinic Receptor Antagonism: Cyclohexylalanine‐Containing Analogues as Potent and Voltage‐Dependent Blockers , 2006, ChemMedChem.
[14] S. Lipton. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond , 2006, Nature Reviews Drug Discovery.
[15] J. Growdon,et al. Current pharmacotherapy for Alzheimer's disease. , 2006, Annual review of medicine.
[16] J. Jaroszewski,et al. N-Alkylation Reactions and Indirect Formation of Amino Functionalities in Solid-Phase Synthesis , 2005 .
[17] M. Witt,et al. On-Resin Carboxy Group Activation of ω-Amino Acids in Solid-Phase Synthesis of Philanthotoxin Analogues , 2005 .
[18] S. Hansen,et al. Side-chain-anchored N(alpha)-Fmoc-Tyr-OPfp for bidirectional solid-phase synthesis. , 2005, Organic letters.
[19] K. Strømgaard,et al. Polyamine toxins: development of selective ligands for ionotropic receptors. , 2005, Toxicon : official journal of the International Society on Toxinology.
[20] P. Usherwood,et al. The effects of conformational constraints and steric bulk in the amino acid moiety of philanthotoxins on AMPAR antagonism. , 2005, Journal of medicinal chemistry.
[21] K. Strømgaard,et al. Synthesis of polyamines and polyamine toxins. An improved alkylation procedure , 2004 .
[22] M. Witt,et al. Solid-phase synthesis of rigid acylpolyamines using temporary N-4,4'-dimethoxytrityl protection in the presence of trityl linkers. , 2004, The Journal of organic chemistry.
[23] L. Wollmuth,et al. Structure and gating of the glutamate receptor ion channel , 2004, Trends in Neurosciences.
[24] M. Witt,et al. Diols as Building Blocks in Solid-Phase Synthesis of Polyamine Toxins by Fukuyama-Mitsunobu Alkylation , 2004 .
[25] S. Hansen,et al. A sequential high-yielding large-scale solution-method for synthesis of philanthotoxin analogues. , 2003, European journal of medicinal chemistry.
[26] P. Krogsgaard‐Larsen,et al. Solid-phase synthesis of polyamine toxin analogues: potent and selective antagonists of Ca2+-permeable AMPA receptors. , 2002, Journal of medicinal chemistry.
[27] T. Kan,et al. Highly Versatile Synthesis of Polyamines by Ns-strategy on a Novel Trityl Chloride Resin , 2002 .
[28] P. Usherwood,et al. Solid-phase synthesis and biological evaluation of a combinatorial library of philanthotoxin analogues. , 2000, Journal of medicinal chemistry.
[29] S. R. Chhabra,et al. Solid-phase synthesis of polyamines using a Dde-linker: philanthotoxin-4.3.3 via an on-resin Mitsunobu reaction , 2000 .
[30] P. Usherwood,et al. Analogues of neuroactive polyamine wasp toxins that lack inner basic sites exhibit enhanced antagonism toward a muscle-type mammalian nicotinic acetylcholine receptor. , 1999, Journal of medicinal chemistry.
[31] S. Walker,et al. The Kinetic Characterization of Escherichia coli MurG Using Synthetic Substrate Analogues , 1999 .
[32] R. Dingledine,et al. The glutamate receptor ion channels. , 1999, Pharmacological reviews.
[33] G. Collingridge,et al. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells , 1996, British journal of pharmacology.
[34] P. Krogsgaard‐Larsen,et al. Neuroactive polyamine wasp toxins: nuclear magnetic resonance spectroscopic analysis of the protolytic properties of philanthotoxin-343. , 1996, Journal of medicinal chemistry.
[35] M. Lebl,et al. A Convenient Preparation of Monosubstituted N,N′-di(Boc)-Protected Guanidines. , 1994 .
[36] P. Usherwood,et al. Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors. , 1990, The Journal of pharmacology and experimental therapeutics.
[37] A. Rosowsky,et al. N.epsilon.-[[2-(Trimethylsilyl)ethoxy]carbonyl] derivatives of tri-L-lysine and tetra-L-lysine as potential intermediates in the block polymer synthesis of macromolecular drug conjugates , 1989 .
[38] P. Usherwood,et al. Structure and synthesis of a potent glutamate receptor antagonist in wasp venom. , 1988, Proceedings of the National Academy of Sciences of the United States of America.